New section in journal of translational medicine: patient-targeted molecular therapies

被引：0

作者：

Bot, Adrian ^{[2
]}

Chiappelli, Francesco ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA

[2] Kite Pharma Inc, Los Angeles, CA 90024 USA

来源：

JOURNAL OF TRANSLATIONAL MEDICINE | 2012年 / 10卷

关键词：

D O I：

10.1186/1479-5876-10-92

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

This Editorial announces a new section in the Journal of Translational Medicine: Patient-Targeted Molecular Therapies. This section is dedicated to the dissemination of targeted molecular therapies in context of patient-centered outcomes research and evidence-based clinical decisions. The focus on patient-targeted molecular therapies - spanning small molecules and biomolecules alike - stems from the unprecedented growth in this arena. This is consonant with the overall objective of the Journal of Translational Medicine, which seeks out to expand firmly to other vast areas of medicine in the domain of translational science, viewed here as the transaction between translational research and translational effectiveness. As we inaugurate this new section in Journal of Translational Medicine, with its mission described in detail in this Editorial, we invite interested scientists to submit their work for publication.

引用

页数：2